Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Sep 3, 2025

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models
06:22

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

3.9K

Mapping CAR T-Cell Design Space Using Agent-Based Models.

Alexis N Prybutok1, Jessica S Yu1,2, Joshua N Leonard1,3,4,5

  • 1Department of Chemical and Biological Engineering, Northwestern University, Evanston, IL, United States.

Frontiers in Molecular Biosciences
|July 29, 2022
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRISPR-Cas-Based Platform for Single-Step Quantification of Monoclonal Antibodies at Point-of-Care.

ACS sensors·2026
Same author

CELLISA - a cell-cell binding assay for evaluation of nanovesicle targeting proteins.

bioRxiv : the preprint server for biology·2026
Same author

Distinguishing Pseudotransduction and True Transduction Enables Characterization and Bioengineering of Extracellular Vesicle-Adeno-Associated Virus Vectors.

Journal of extracellular vesicles·2026
Same author

Association of neurogenic orthostatic hypotension with cognitive decline in Parkinson's disease: a longitudinal cohort study.

Frontiers in neurology·2026
Same author

Individuals' Perceptions of the Efficacy, Quality, and Safety of Care Accessed via a Telemedicine Platform: A Retrospective Analysis of Survey Data.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association·2026
Same author

Variable deep learning training horizons reveal the temporal complexity of biological systems.

microPublication biology·2026
Same journal

Mesenchymal stem cells-derived extracellular vesicles as a novel drug delivery carrier: engineering strategies and clinical safety estimation.

Frontiers in molecular biosciences·2026
Same journal

Preparation and analysis of tobacco glycosides, and the relationship between glycoside aglycones and pyrolysis products: a review.

Frontiers in molecular biosciences·2026
Same journal

Peritoneal metastasis in pancreatic cancer: molecular mechanisms, microenvironmental remodeling, and emerging intraperitoneal interventions.

Frontiers in molecular biosciences·2026
Same journal

Insights from LC-MS-based cerebrospinal fluid metabolomics in tuberculous meningitis.

Frontiers in molecular biosciences·2026
Same journal

Emerging roles of Notch signaling in the tumor microenvironment of digestive system cancers.

Frontiers in molecular biosciences·2026
Same journal

Adenosine metabolism as an endogenous protective mechanism in response to upstream ischemic injury.

Frontiers in molecular biosciences·2026
See all related articles
This summary is machine-generated.

This study introduces CARCADE, a computational model for chimeric antigen receptor (CAR) T-cell therapy. CARCADE simulates treatment variables to optimize CAR T-cell strategies for cancer, accelerating solid tumor therapy development.

Area of Science:

  • Immunology
  • Computational Biology
  • Oncology

Background:

  • Chimeric antigen receptor (CAR) T-cell therapy is a promising cancer treatment, but challenges remain for solid tumors.
  • Testing CAR T-cell design strategies in vitro and in vivo is costly and time-consuming.

Purpose of the Study:

  • To develop a computational framework, CARCADE, to simulate CAR T-cell therapy.
  • To investigate the impact of design choices and tumor features on treatment outcomes using in silico experiments.

Main Methods:

  • Extended the Agent-based Representation of Cells And Dynamic Environments (ARCADE) framework to include CAR T-cell agents (CARCADE).
  • Conducted in silico experiments varying CAR T-cell dose, CD4+:CD8+ CAR T-cell ratio, CAR-antigen affinity, and cancer/healthy cell antigen expression.
Keywords:
CAR T-cellagent-based modelcell population dynamicsemergent dynamicsmodel-guided designsimulation

More Related Videos

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.2K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.5K

Related Experiment Videos

Last Updated: Sep 3, 2025

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models
06:22

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

3.9K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.2K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.5K

Main Results:

  • Tuning CAR affinity influences IL-2 production by balancing CAR T-cell proliferation and effector function.
  • Identified a novel multi-feature treatment strategy for balancing selectivity and efficacy.
  • Revealed the impact of spatial effects on treatment performance in different contexts.

Conclusions:

  • CARCADE facilitates a deeper understanding of CAR T-cell treatment design.
  • The model can accelerate the identification of promising CAR T-cell strategies for solid tumors.
  • CARCADE aids in optimizing the design-build-test cycle for CAR T-cell therapies.